Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;1(1):19.
doi: 10.1186/s40981-015-0023-4. Epub 2015 Oct 26.

Thoracic paravertebral block reduced the incidence of chronic postoperative pain for more than 1 year after breast cancer surgery

Affiliations

Thoracic paravertebral block reduced the incidence of chronic postoperative pain for more than 1 year after breast cancer surgery

Hiroki Shimizu et al. JA Clin Rep. 2015.

Abstract

Background: Thoracic paravertebral block (TPVB) is used to reduce pain after breast cancer surgery (BCS), but the pain-reduction effects more than 1 year after surgery are unclear.

Findings: Fifty-one patients underwent BCS at the Niigata City General Hospital from December 2009 through March 2010. To evaluate the long-term effects of TPVB in the reduction of chronic pain after BCS, we retrospectively reviewed the anesthesia charts and medical records of these patients and conducted telephone surveys regarding postoperative pain 13-17 months after surgery in 46 of these patients. Among the 46 patients enrolled in this study, 17 experienced chronic pain. There was a significant difference in the percentage of patients that received TPVB among those with and without chronic pain (patients with chronic pain 5/17 (29.4 %), patients without chronic pain 18/29 (62.1 %), p = 0.039). The pain score 3-6 h after surgery was significantly higher in the patients with chronic pain than without (p = 0.016). Bivariate logistic regression revealed that TPVB and pain score 3-6 h after surgery were independent predictive factors of chronic pain after BCS.

Conclusions: These results indicate that TPVB has the potential to reduce chronic pain for more than 1 year after BCS.

Keywords: Breast cancer surgery; Chronic postoperative pain; Thoracic paravertebral block.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
CONSORT diagram of this study
Fig. 2
Fig. 2
Average doses of remifentanil administered during breast cancer surgery in patients with or without TPVB. In patients with TPVB, the remifentanil doses were significantly smaller than in those without TPVB
Fig. 3
Fig. 3
Patient distribution of postoperative pain scores 0–3, 3–6, and 6–24 h after surgery in patients with and without chronic pain. The pain score 3–6 h after surgery was significantly higher in the patients with chronic pain than in the patients without chronic pain. However, there was no significant difference in the pain scores 0–3 and 6–24 h after surgery between the two groups, although the patients with chronic pain tended to experience more pain than the patients without chronic pain at each time interval

Similar articles

Cited by

References

    1. International Agency for Research on Cancer WHO. CANCERMondial Lyon, France2010 [cited 2014 July 28]. Available from: http://www-dep.iarc.fr/.
    1. Group UCSW. United States Cancer Statistics: 1999–2010 incidence and mortality web-based report. 2013. Available from: www.cdc.gov/uscs.
    1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241. doi: 10.1056/NEJMoa022152. - DOI - PubMed
    1. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–933. doi: 10.1016/S1470-2045(10)70207-2. - DOI - PMC - PubMed
    1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232. doi: 10.1056/NEJMoa020989. - DOI - PubMed

LinkOut - more resources